论文部分内容阅读
目的探讨高危前列腺增生经尿道电切手术的安全性及临床效果。方法选取前列腺增生患者120例,按照随机分配原则分为治疗组和对照组,每组60例,所有患者采用术前风险评估,处理风险因素。治疗组采用经尿道电切术,对照组采用常规电切术。对比两组患者治疗前后前列腺症状评分、最大尿流率、残余尿量以及手术时间、切除组织、术后并发症等。结果两组治疗后前列腺症状评分、最大尿流率、残余尿量等方面相比差异无统计学意义(P>0.05),但是治疗组手术时间、切除组织以及术后并发症发生例数显著优于对照组(P<0.05),治疗组临床效果显著。结论对于高危前列腺增生患者采用经尿道电切手术是一种安全可靠的治疗方法,具有手术时间短、对患者的创伤小等优势,值得临床推广应用。
Objective To investigate the safety and clinical efficacy of transurethral resection of benign prostatic hyperplasia (BPH). Methods A total of 120 patients with benign prostatic hyperplasia (BPH) were selected and randomly divided into treatment group and control group according to the principle of random distribution. Each group included 60 patients. All patients were treated with risk assessment before operation. In the treatment group, transurethral resection was used, while in the control group, conventional resection was performed. Prostate symptom score, maximal uroflow rate, residual urine volume and operation time, resection organization and postoperative complications were compared between two groups before and after treatment. Results There was no significant difference in prostate symptom score, maximal uroflow rate, residual urine volume after treatment between two groups (P> 0.05), but the number of operation time, resection organization and postoperative complications in the treatment group were significantly better In the control group (P <0.05), the clinical effect of the treatment group was significant. Conclusion The transurethral resection of prostate in high-risk patients with benign prostatic hyperplasia is a safe and reliable method of treatment. It has the advantages of short operative time and small trauma to patients, which is worthy of clinical application.